Introduction
Chlorine (Cl 2 ) is widely used for various industrial and manufacturing applications and often transported through densely populated areas. Accidental exposure to high doses of these halogens has been reported in mass casualty scenarios worldwide (1) (2) (3) . In addition, exposure to these halogens remains a concern in the military arena underscoring the need to understand detailed mechanisms of toxicity and for targeted post-exposure therapeutics.
Recent studies have elucidated the temporal toxicity profile resulting from Cl 2 gas exposure. Using murine and rodent models, we and others have shown that post-exposure injury occurs over hours to weeks characterized by acute lung injury (increased endothelial and epithelial permeability and neutrophilic inflammation), pulmonary and systemic vascular dysfunction (loss of nitric oxide homeostasis), reactive airways, pulmonary fibrosis, bronchiolitis obliterans, myocardial and dermal injury (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) . Chlorine and its hydration product, hypochlorous acid are highly reactive limiting their direct reactions to either low molecular weight antioxidants present in the epithelial lining fluid or targets on the surfaces of epithelial and inflammatory cells (14) . This suggests that Cl 2 induced injury to the hyaluronan, present mainly in the lung interstitial matrix as well as to extrapulmonary tissues and vasculature (13, 15- 4 chloropalmitic acid (2-Cl-PA) and 2-chlorostearic acid (2-Cl-SA) (Figure 1 ) or reduced to the respective 2-chlorofatty alcohols. Additionally, recent studies have shown 2-Cl-Pald and 2-Cl-Sald are targets for nucleophilic attack by glutathione (GSH) leading to glutathionylated adducts of palmitaldehyde and stearaldehyde respectively (26) . Moreover, these fatty acid species have been detected as being free or esterified. Furthermore, emerging studies indicate unique biological effects of Cl-lipid in stimulating inflammation, promoting cell-death and dysfunction in eNOS-signaling (19, 21, 23, (26) (27) (28) (29) (30) , which are also all features of post-Cl 2 gas toxicity (4, 15) . Chlorinated lipids are predicted to be formed via direct reactions of Cl 2 gas with the vinyl ether bond in plasmalogens leading us to hypothesize that these species may be mediators of post-Cl 2 gas toxicity. In this study, we show that Cl-lipid and their GSH adducts are formed after Cl 2 gas exposure, and provide evidence that they are are potential mediators of postexposure toxicity.
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Materials and Methods
Materials:
Unless stated otherwise all reagents were purchased from Sigma (St. Louis, MO, USA). Male (25-27g, 10-12 weeks of age) C57/bl6 mice and rats were purchased from Harlan (Indianapolis, IN, USA) and kept on 12h light-dark cycles with access to standard chow and water ad libitum prior to and post chlorine gas exposure.
Methods
Mouse or rat exposure to chlorine gas. Whole body exposures of male mice or male rats to Cl 2 gas were performed as previously described (31) (32) (33) . Exposures were performed with either 2 mice or rats in the same chamber at any one time, and all exposures were performed between 8am-12pm. Exposure conditions were 400ppm Cl 2 in air for 30min using either 400ppm Cl 2 tanks or by mixing 1000ppm Cl 2 gas with compressed air. Flow meters were used to control flow rates to achieve the chamber Cl 2 target concentrations. A bubble flow meter was used to validate their performance on a weekly basis. In each case, immediately following exposure, mice were returned to room air. All experiments involving animals were conducted according to protocols approved by the UAB IACUC. Food and water were provided ad libitum.
Inducing Neutropenia: C57Bl/6 mice were rendered neutropenic as described previously (34) by intraperitoneal injection with 200µg of either anti Ly-6G (clone 1A8)(Bxcel: cat# BE0075-1) or IgG2a Isotype control (Bxcel: cat# BE0089) 24hr prior to Cl 2 gas exposure.
Cl-lipids measurement:
Mice were euthanized at various times post-Cl 2 gas exposure using a mixture of ketamine/xylazine (200/10 mg/kg) administered by i.p injection. Blood was collected via cardiac puncture and lungs excised. Blood was centrifuged at 6000 rpm for 5 minutes to obtain the plasma fraction. Lungs and plasma samples were flash frozen in liquid nitrogen and stored at -80 o C. Samples were shipped overnight on dry ice to Dr. Ford at St. Louis University. Free and total (i.e. free + esterified) chlorinated lipids shown in Figure 1 were measured as previously described by LC/MS following Dole extraction. Measurement of glutathione adducts of 2-Cl-Pald and 2-Cl-Sald: Plasma and lung samples were analyzed as previously described (26) Both plasma and lung were then extracted according to a similar Bligh and Dyer method as described for the Cl-lipids (35) ; however, the aqueous layer was saved as the GSH adducts partition to the aqueous layer. The organic layer was subsequently washed with 1 volume MeOH:H₂O (1:1 v:v) and combined with the previous aqueous layer. The combined aqueous layers were diluted with 1/3 volume of H₂O and extracted on a Strata-X followed by ESI-LC/MS/MS quantitation as previously described (26) . NaOCl (final concentration 2 mM) was then added dropwise to the constantly stirring solution and then incubated for 60min at 37°C. Triflouroacetic acid (TFA) was then added to a final concentration of 0.1% and the 3-[ 13 C 9 ]chlorotyrosine was purified by HPLC on a C18 column (Beckman Ultrasphere, 5 µm resin, 4.6x250mm). Amino acids were applied to the column equilibrated with 0.1% TFA in H 2 O and eluted with 0.1% TFA in methanol. Fractions were collected monitoring at 276 nm.
Tissue and plasma hydrolysis for Chlorotyrosine measurement: Plasma and lung samples were collected and prepared as previously described (37) Intranasal administration of Cl-lipids. A 5mM stock of palmitic acid, palmitaldehyde , 2-Cl-PA, 2-ClPald in 100% ethanol was diluted ten-fold in PBS prior to administration to mice. C57bl/6 male mice were divided into 6 groups. The mice were anesthetized using isoflurane and PBS, 10% ethanol or each fatty acid (50µl, equivalent to 25nmol) was administered into the nares (intranasal). Mice were returned to room air and upon waking returned to their cages and then sacrificed at 6h or 24h post-administration. (38) .
Acute lung injury measurements Mice were euthanized with intraperitoneal ketamine and xylazine (100 and 10mg/kg body weight respectively). An incision was made at the neck to expose the trachea and a 3mm endotracheal cannula inserted. Lungs were lavaged with 3 X 1 ml of PBS; ∼1.8-1.9ml was recovered in all groups. Mice were then ex-sanguinated by cardiac puncture for collection of blood.
Recovered aliquots of lavage fluid were kept on ice, and centrifuged immediately at 300g for 10 min to pellet cells. Supernatants were removed and stored on ice for protein analysis using the Bio-Rad Protein Assay Reagent Kit compared to BSA standards. Cells were re-suspended in 100μl PBS and counted using a Neubauer hemocytometer. Cells were then placed on slides using a cellspin (Tharmac, Germany) and stained using a two stain set consisting of EosinY and a solution of thiazine dyes (Quik-Stain, Siemens, Washington DC). Differential counts (specifically monocytes, neutrophils, and lymphocytes) were then performed on slides via light microscopy.
Vessel studies: Mice were euthanized and aorta excised and sectioned into 2-3mm segments and then used for vessel bioactivity assays. All vessel bioassay studies were performed in indomethacin (5μM) pre- doses ranging from 1nM to 3000nM. Endothelium-dependent vasodilator responses were tested by administering cumulative doses of acetylcholine (Ach), ranging from 1nM to 3000nM after tension development at maximal PE dose. In subsequent experiments, vessels were sub-maximally contracted (50% of KCl response) with PE (300nM-1000nM). When tension development reached a plateau, endothelium-independent vasodilator responses were induced by administering cumulative doses of the nitric oxide donor MAHMANONOate (MNO).
Statistical Analysis:
All results are reported as the mean ± SEM significant differences were calculated as p<0.05 by one-way ANOVA with Dunnett's multiple comparison post-test or 2-way ANOVA with
Bonferroni post test using GraphPad Prism 5. One data point from 72h group for chlorinated lipid time course measurements was excluded based on Grubb's outlier test (P<0.05).
Results
Chlorine gas exposure increases lung levels of Cl-lipids
We first tested if Cl 2 gas exposure resulted in increases in Cl-lipid. C57bl/6 mice were exposed to Cl 2 gas 400ppm, 30min and then sacrificed at various times (0-72h) thereafter. The predicted initial products of Cl 2 reactions with plasmalogens are the 2-chlorofatty aldehydes. Figure 2 shows that both 2-ClPald and 2-by guest, on October 14, 2017
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Cl-Sald are formed in the lungs after Cl 2 gas exposure with the levels being highest immediately postexposure. Both 2-chlorofatty aldehydes decreased by ∼50-75% within 30min post exposure, which remained at a steady state over the next 6hr. For 2-Cl-Pald, levels decreased further at 12h, but still remained 2-fold higher compared to baseline (P<0.05 by t-test) at 24h. Thereafter levels decreased to basal. Similar temporal changes were observed for 2-Cl-Sald. Figure 3A shows changes in free and esterified 2-Cl-PA and 2-Cl-SA in the lungs; esterified levels representing total minus free. Both of these 2-chlorofatty acids are formed via oxidation of aldehydes shown in Figure 2 . Free 2-Cl-PA levels were highest immediately post Cl 2 exposure and then decreased to basal levels over 12h. Interestingly, esterified 2-Cl-PA levels also increased to similar extent as free levels immediately post Cl 2 exposure, but remained at this high level for 6h and then slowly decreased over 72h; esterified 2-Cl-PA were still significantly elevated (8-fold) relative to basal at 72h (p<0.05 by t-test).
Also, at all time points between 0.5-72h, esterified 2-Cl-PA levels were greater compared to free levels. Figure 3B shows changes in free and esterified 2-Cl-SA. Free levels showed a similar temporal profile compared to 2-Cl-PA with levels decreasing after the cessation of exposure. Esterified 2-Cl-SA also increased initially and then decreased over 2h and then reaching a steady state that was maintained over 24h. Notably, levels of 2-Cl-SA were lower compared to 2-Cl-PA. Figure 4A -B shows that both free and esterified 2-Cl-PA and 2-Cl-SA increase in the plasma post-Cl 2 exposure. Similar to the lung, levels of free forms were highest immediately post-exposure, decreasing over 6-12h thereafter. Esterified Cl-lipid levels immediately post-exposure trended to be higher than air (p<0.05 by t-test for t=0 and 0.5h post exposure), and increased between 2-6h (reaching significance by 1-way ANOVA), and then decreasing thereafter. Levels at 48h and 72h remained elevated (5-20 fold) compared to air (by t-test). Also, between 2-48h, esterified forms of both 2-Cl-PA and 2-Cl-SA were higher than the respective free forms, and 2-Cl-PA was typically higher than 2-Cl-SA.
Chlorine gas exposure increases circulating levels of Cl-lipids
Chlorine gas exposure increases glutathione-aldehyde adducts
Our recent studies demonstrate that 2-chloro-fattyaldehydes react with glutathione (GSH) to form aldehyde conjugates with the elimination of chlorine (Figure 1 ) (26). Fig 3C and 4C show that GSHadducts with Pald and Sald increase in the lung and circulation respectively. Temporal changes of these adducts are similar to changes in free 2-chloro-lipids in the lung. In the plasma however, formation is slower peaking at 4h and then levels declined thereafter.
Effects of Cl 2 gas on Cl-Tyr formation
Fig 3D and 4D shows that Cl 2 exposure also increased lung and plasma 3-chlorotyrosine respectively, with levels being highest early post exposure then declining towards basal 12-24h thereafter. Figure 5 shows that Cl-lipid were also increased in rats after similar regiments of Cl 2 gas exposure both in the lungs (Fig 5A-B ) and the plasma (Fig C-D) , with significant increases still evident 24h after exposure. These data underscore the possibility that Cl-lipid formation is uniform across different animal species after Cl 2 -gas exposure.
Chlorine gas exposure increases lung and circulating Cl-lipids in rats
Effects of neutropenia on Cl-lipid formation
To delineate the relative contribution of chlorine-gas vs. endogenous PMN (MPO) dependent formation of chlorinated fatty acids, mice were rendered neutropenic and then exposed to Cl 2 gas. Figure 6 shows neutropenia had no effect on esterified 2-Cl-fatty acid, 2-Cl-fatty acid aldehydes in the lung, nor on 2-Clfatty acids in the plasma. This is most likely due to the fact that levels of chlorinated fatty acids formed by activated neutrophils are orders of magnitude less than those formed by the reaction of inhaled Cl 2 and
HOCl with plasmalogens.
Effects of Cl-lipid on ALI indices in vivo
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To test if Cl-lipids could mediate ALI in vivo, 2-Cl-PA and 2-Cl-Pald or their respective native (nonchlorinated) fatty acids / aldehydes were administered intranasally to mice and ALI assessed 6-24h
thereafter. The final nominal administered dose of Cl-lipids was 12pmol / mg lung, which is comparable to maximal levels of 2-Cl-PA and 2-Cl-Pald measured in the lung after chlorine gas exposure (5pmol / mg lung), and we note that the actual concentration of applied Cl-lipid that reach the distal airways is likely to be less than 5% of the intranasal dose. Figure 7A shows that 6h after administration, 2-Cl-PA significantly increased BAL protein compared to palmitic acid alone, with trends towards increased protein for 2-Cl-Pald also noted. No differences between Cl-lipid and respective fatty acid controls nor vehicle controls was observed 24h after administration following this single intranasal administration. Figure 7B shows that both 2-Cl-PA and 2-Cl-Pald significantly increased levels of inflammatory cells in the BAL compared to non-chlorinated fatty acids at 6h, that comprised both macrophages and neutrophils ( Figure 6C ). No significant differences were observed at 24h, although trends towards increased inflammatory cells are noted. Figure 6D shows that there were no significant changes in the chemokine KC in the BAL 24h after 2-Cl-PA administration.
Effects of Cl-lipid on airway reactivity
Airway hypersensitivity is a feature of post-Cl 2 gas exposure toxicity. To test if Cl-lipid play a role in this process, Cl-lipid were administered as described above and basal-and methacholine-induced airway resistance and elastance measured 24h thereafter. Figure 8A -B show that methacholine induced a dosedependent increase in resistance. This was exacerbated with 2-Cl-PA at all methacholine doses, and with 2-Cl-Pald also, albeit only at the highest methacholine dose tested. Fig 8C-D show changes in elastance.
Similar to resistance, 2-Cl-PA exaggerated methacholine effects, however 2-Cl-Pald had no effect.
Finally, Figure 8E -F show basal effects of Cl-lipid treatment of reactive airways. Small but significant increases in basal resistance and elastance were observed only with 2-Cl-PA.
Effects of Cl-lipid of systemic vascular dilation
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Our previous studies have shown that eNOS-dependent vasodilation becomes inhibited post Cl 2 gas exposure (15, 16) and other groups have shown that Cl-lipid addition to cultured endothelial cells inhibits eNOS activity (27) . We therefore tested eNOS-dependent vasodilation of aorta isolated 24h after intranasal Cl-lipid administration. Fig 9A shows that PE induced contraction in a dose-dependent manner that did not differ among experimental groups. Fig 9B shows that the acetylcholine (Ach) induced vasodilation, which is eNOS-dependent, was similar in aorta isolated from native fatty acid or aldehydes treated mice. This response was significantly blunted (indicated by right shifts in dose-curves) however in aorta isolated from either 2-Cl-PA or 2-Cl-Pald treated mice. Fig 9C shows that MNO-dependent vasodilation was similar in all groups indicated that smooth muscle responsiveness to NO-donors was not altered.
Discussion
During exposure, Cl 2 gas reacts with the airways to cause acute toxicity characterized by airway cell death and activation of pathways leading to post-exposure pulmonary inflammation and increased permeability of the blood gas barrier to plasma proteins. It is likely that the post-exposure phase reflects both tissue responses to the initial insult and ongoing injury to secondary derived species. The mediators and mechanisms remain unclear underscoring the need to understand Cl 2 gas derived products. Cl 2 gas exposure also leads to tissue inflammation and microcirculatory dysfunction in extrapulmonary tissues.
For example animals exposed to Cl 2 and returned to room air develop endothelial and myocardial dysfunction and failure (13, 16) . This pattern of injury is observed with many chemically distinct inhaled irritants and pollutants (e.g. ozone, particulate matter) (39) (40) (41) (42) . A key question is how is the primary reactivity of the inhaled species in the lungs transduced to the periphery, with one model proposed being that the initial insult forms a secondary, longer lived species that can egress into the circulation. There are several Cl 2 -specific products that may be formed including chloramines (18, 43) ; here we tested a role for Cl-lipid.
We used mouse and rat models of Cl 2 gas exposure that are sub-lethal but which result in post-exposure ALI, RAS and systemic inflammation. Both 16 carbon and 18 carbon chlorinated fatty acids and aldehydes were formed following Cl 2 gas exposure. For all chlorinated lipid species, the levels were greatest immediately post-exposure suggesting direct formation during the Cl 2 gas exposure. The levels of Cl-lipid decreased after exposure. The kinetics of this decay was not a simple first or second order process however, and was unique to the specific Cl-fatty acid / aldehyde species. That said, three distinct phases for the post-exposure decay could be generalized. The first was a rapid phase in which ∼50-70% of the Cl-lipid formed decreased within 30min post-exposure. This was followed by a second phase where levels did not change, or changed very slightly over 6h. Whether this reflects Cl-lipid stability (lack of metabolism), or a steady-state (where formation equals decay and / or wash out) is not known. We speculate lack of metabolism, since eliminating neutrophils, the major source of endogenous chlorinating species did not change Cl-lipid levels. The final phase was a slow (>12h) decay back to basal levels. An additional consideration is the relationship of free and esterified pools of chlorinated fatty acids. The source of 2-chlorofatty acids is 2-chlorofatty aldehyde (the product of chlorine oxidation of plasmalogens). The biological half-life of the esterified pool is longer than that of the free pool. The longer biological half-life of esterified 2-ClFA in plasma makes this a better biomarker of chlorine gas exposure compared to free 2-ClFA since it was detectable 72 h after exposure. One question that remains is to determine the complex lipid pool esterifying 2-chlorofatty acids. This requires further study but we note that esterified levels were higher than free forms likely reflecting esterified pools as a more stable, perhaps biologically-inert pool, to store bioactive 2-chlorofatty acids.
Importantly, 2-chlorofatty acids also increased in the plasma. For the free forms, levels were highest immediately post-exposure, whereas esterified forms increased post-exposure. This suggests an active esterification of free Cl-lipid and / or egress of esterified Cl-lipid from the lungs to the circulation. As with the lung levels, neutropenia had no effect on plasma Cl-lipid levels suggesting the contribution of PMN-derived myeloperoxidase activity to circulating Cl-lipid levels is minimal. This is consistent with our prior experiences where the levels of Cl-lipid formed in models of PMN-inflammation (21) , are still much lower compared to levels observed here with Cl 2 gas formation. Collectively, these data show that plasmalogens are significant targets for Cl 2 gas resulting ultimately in 2-chlorofatty acid production, and also highlight our lack of understanding of how these lipid species are metabolized. In this regard, fatty aldehyde adducts with GSH increased post-chlorine exposure likely due to reactions between 2-chloroaldehydes and GSH as recently described, and confirming the concept that the redox milieu is key in controlling Cl-lipid levels and metabolism (19, 26) . We also recognize that there may be a host of other Cl-lipid species formed either directly from Cl 2 gas or after reaction of formed Cl-lipid with biomolecules or chlorinated amino acids which have been shown to damage SERCA and lung ion channels (13, 43) , measurement of these is required to fully understand metabolism and fate of formed Cl-lipid.
In addition, circulating levels of Cl-lipid over the first 6h post-exposure were several orders of magnitude higher compared to basal, and remained at least 2-fold higher at 24-48h post exposure. Notably, levels of role for MPO-derived HOCl can be excluded however based on similar Cl-lipid levels in neutropenic mice exposed to Cl 2 gas. The key point for considering Cl-lipid as biomarkers for Cl 2 gas exposure is that the levels of Cl-lipid formed after Cl 2 gas exposure will be significantly higher than formed during endogenous inflammation. This concept could also be applied for other halogens. Indeed, Br-fatty acids are increased in bromine exposed mice (Matalon et al, unpublished data). We also showed formation of 3-Cl-tyrosine in the lungs and plasma of mice exposed to Cl 2 gas consistent with a recent study showing formation of both 3-Cl-Tyr and di-chloro-tyr after Cl 2 exposure of blood ex vivo (47) . Similar to Cl-lipid, 3-Cl-Tyr levels declined 12-24h post exposure, although at 24h, 3-Cl-Tyr levels returned to baseline, whereas Cl-lipid remained 10-20 fold higher suggesting a greater sensitivity for the latter in detecting Cl 2 gas exposure. We also appreciate there are a myriad of other chlorine-dependent products that are likely formed after Cl 2 gas exposure that could be used as biomarkers. While some such as chloramines may mediate Cl 2 gas toxicity (18, 43) , their relative short lifetimes in vivo preclude them as useful biomarkers.
Future studies need to more extensively compare Cl-lipid with other chlorinated modifications for biomarker assessments.
Beyond a biomarker role, we also evaluated the potential for Cl-lipid to mediate post-Cl 2 gas exposure toxicity. Previous studies have shown that Cl-lipid can elicit cell death in endothelial and neuronal cells, promote cell permeability leading to compromised blood-brain barrier, inhibit endothelial function by inhibiting eNOS-dependent signaling and promote the inflammatory potential of endothelial cells, neutrophils and macrophages (27, 28, 30, 48, 49) . The precise mechanisms linking Cl-lipid to these responses remains under investigation but modulation of MAP kinases and perturbation of redoxsignaling are likely candidates. Indeed Cl-lipid will be more electrophilic compared to parent fatty acid (50) and fatty acid electrophiles are known to change redox signaling and alter cell function in various inflammatory disease settings. We therefore conducted proof of concept studies to test if intranasal administration (into the lungs) of 2-Cl-PA or 2-Cl-Pald could elicit effects similar to that observed after Cl 2 gas exposure. Changes in lung endothelial and / or epithelial permeability were indicated by increased BAL protein levels, consistent with pro-permeability effects of Cl-lipid. Also, similar to Cl 2 gas, chlorinated lipids increased levels of inflammatory cells, however these were predominantly macrophages, with smaller increases in neutrophils. Cl 2 gas increases both macrophages and neutrophils, with neutrophils being predominant. Consistent with a minimal pro-neutrophil effect, neither 2-Cl-PA nor 2-Cl-Pald had any effect on pro-neutrophilic chemokines. Ongoing studies are exploring the mechanisms by which Cl-lipid increase airway macrophage numbers and suggest regulatory roles on airway immunity.
With respect to reactive airways, 2-Cl-16:0FA had a modest effect on basal airway resistance, and increased methacholine sensitivity compared to vehicle or non-chlorinated fatty acid. from the lung to the periphery to elicit extrapulmonary effects characterized by eNOS inhibition and led to the hypothesis that plasma Cl-lipid formed after Cl 2 gas exposure may mediate extrapulmonary toxicities to the vasculature and heart (13, 15, 16 carbon chlorofatty acids is not known, but testing of the combination is required to better assess potential role of Cl-lipid in Cl 2 gas exposure toxicity. Also, intranasal administration does not only lead to airway deposition and it is possible that some effects could be mediated by direct absorption of Cl-lipid into the blood via vessels perfusing the nares and upper airways. Notwithstanding these limitations, collectively these data suggest that a single instillation of chlorinated palmitate resulted in an increase of airway resistance and alveolar permeability which are also seen in mice exposed to Cl 2 and returned to room air and suggest that targeting of Cl-lipid metabolism to facilitate clearance or limit reactivity may provide a new perspective on therapeutics to limit post-exposure toxicities. Male Sprague Dawley rats were exposed to Cl 2 gas (400ppm, 30min) and then brought back to room air. At the indicated times thereafter, lungs (panels A-B) and plasma (panels C-D) were collected and free and esterified forms of 2-Cl-palmitic acid (2-Cl-PA) and 2-Cl-stearic acid (2-Cl-SA) measured. Data are mean ± SEM (n=3) *p<0.05 relative to air by t-test. 
